Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Philip J. ferrone, M.D., Long Island Vitreoretinal Consultants
ClinicalTrials.gov Identifier:
NCT00440609
First received: February 23, 2007
Last updated: August 1, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)